
| Please Note: You will notice frequent revisions to Rutgers websites as the university's transformation of undergraduate education progresses at the New Brunswick campuses. |
Judith E. O'Grady is Senior Vice President of Global Regulatory Affairs, Quality Assurance and Clinical Affairs for Integra LifeSciences Corporation, Corporate office. Ms. O'Grady has worked in the areas of medical devices and collagen technology for over 20 years. Prior to joining Integra, Ms. O'Grady worked for Colla-Tec, Inc., a Marion Merrell Dow Company. During her career she has held positions with Surgikos, a Johnson & Johnson company, and was on the faculty of Boston University College of Nursing and Medical School. Ms. O'Grady led the team that obtained the FDA approval for INTEGRA® Dermal Regeneration Template, the first skin regenerative product approved by the FDA, DuraGen, DuraGen Plus Dural Regeneration Matrices, NeuraGen Nerve Guide as well as over 500 FDA and international submissions and approvals. She has managed US and International FDA Inspections and ISO Audits/Certifications. She has presented many programs on the Approval process for Medical Devices at seminars in the US and internationally. She has met with many US and International Regulatory agencies regarding the approval process of implantable medical devices. She has performed Regulatory Due Diligence on several of the company’s acquisitions. She received her B.S. degree from Marquette University and M.S.N. in Nursing from Boston University and is Regulatory Affairs certified.